Fang Wang

Dr. Fang Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
FZFeitao Zhao
Feitao Zhao
LFLili Fan
Lili Fan
JYJumei Yang
Jumei Yang
MYMingjun Yang
Mingjun Yang
CZChun Zhang
Chun Zhang
YWYonggang Wang
Yonggang Wang

14 September 2024 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SYShuhong Yang
Shuhong Yang
XRXinxin Ren
Xinxin Ren
JLJia Liu
Jia Liu
YLYan Lei
Yan Lei
MLMinqian Li
Minqian Li
XCXiaohui Chen
Xiaohui Chen

26 July 2025 in Bioorganic Chemistry
Verified
Journal Article
Closed access
FZFeitao Zhao
Feitao Zhao
JLJinhui Lv
Jinhui Lv
MYMingjun Yang
Mingjun Yang
FZFei Zhang
Fei Zhang
CZChun Zhang
Chun Zhang
YWYonggang Wang
Yonggang Wang

29 May 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
FLFeifan Leng
Feifan Leng
RXRuiying Xia
Ruiying Xia
JPJianying Pei
Jianying Pei
YSYuzhe Shi
Yuzhe Shi
CGChenjie Gao
Chenjie Gao
YLYan Li
Yan Li
Breast cancer metastasis remains the leading cause of cancer-related mortality and is closely linked to immune evasion and tumor microenvironment (TME) remodeling. Emerging evidence suggests that intratumoral microbiota (ITM), typically low in biomass and predominantly intracellular, may be associated with tumor progression. This review summarizes the compositional features of ITM and their potential roles in metastasis, including epithelial–mesenchymal transition (EMT), circulating tumor cell (CTC) survival, pre-metastatic niche formation, and distant colonization. Mechanistically, ITM may influence these processes through immune-related signaling pathways (e.g., PRR-mediated cascades) and modulation of immune cell function. However, current evidence is largely derived from preclinical or correlative studies, and causal roles in human breast cancer remain unproven. Methodological challenges associated with low biomass further complicate interpretation. We also discuss microbiota-targeted strategies, including probiotics, antibiotics, and fecal microbiota transplantation, which remain experimental. Future studies using rigorous methodologies and longitudinal human data are required to clarify the role of ITM and its clinical potential.

8 February 2025 in Biological Rhythm Research
Verified
Journal Article
Closed access
SYShuhong Yang
Shuhong Yang
YLYan Lei
Yan Lei
MLMinqian Li
Minqian Li
XRXinxin Ren
Xinxin Ren
FWFang Wang
Fang Wang
XCXiaohui Chen
Xiaohui Chen